logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Dermatologic Disorders

    Medications for Dermatologic Disorders

    FiltersReset Filters
    24 results

    • alacort

      (Hydrocortisone)
      Crown Laboratories
      Usage: Topical corticosteroids are indicated for relief of inflammation and itching associated with corticosteroid-responsive skin disorders.

    • amcinonide

      (amcinonide)
      Solubiomix, LLC
      Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

    • analpram hc

      (hydrocortisone acetate and pramoxine hydrochloride)
      Sebela Pharmaceuticals Inc.
      Usage: Topical corticosteroids are used to relieve inflammation and itching associated with skin conditions that respond to corticosteroids.

    • betamethasone dipropionate

      (Betamethasone Dipropionate)
      Actavis Pharma, Inc.
      Usage: Betamethasone dipropionate cream is indicated for treating inflammatory and itchy skin conditions responsive to corticosteroids in patients aged 13 years and older.

    • betamethasone dipropionate usp, 0.05%

      (Betamethasone Dipropionate USP, 0.05%)
      TruPharma LLC
      Usage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.

    • clobetasol propionate

      (clobetasol propionate)
      IPG PHARMACEUTICALS, INC.
      Usage: Clobetasol propionate cream is indicated for relieving inflammatory and itchy symptoms of corticosteroid-responsive skin conditions. It should not be used for more than 2 weeks or exceed 50 g per week, especially in pediatric patients under 12, due to potential HPA axis suppression.

    • clobetasol propionate

      (Clobetasol Propionate)
      Glenmark Pharmaceutcials Inc., USA
      Usage: Clobetasol propionate cream is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive dermatoses. Treatment should not exceed 2 weeks or 50 g/week to prevent HPA axis suppression. It's not recommended for pediatric patients under 12 years. Discontinue when control is achieved or reassess if no improvement is seen in 2 weeks.

    • desonide

      (Desonide)
      Alembic Pharmaceuticals Inc.
      Usage: Desonide lotion is a low to medium potency corticosteroid used to relieve inflammation and itching associated with corticosteroid-responsive skin conditions.

    • desoximetasone

      (Desoximetasone)
      Lupin Pharmaceuticals, Inc.
      Usage: Desoximetasone cream USP, 0.25% is indicated for the relief of inflammatory and itching symptoms associated with corticosteroid-responsive skin conditions.

    • desoximetasone

      (Desoximetasone)
      Lupin Pharmaceuticals, Inc.
      Usage: Desoximetasone cream USP, 0.05% is indicated for alleviating inflammation and itching associated with corticosteroid-responsive skin disorders.